Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

ClinicalTrials.gov is a web-based resource that provides patients, their family members, health care professionals, researchers, and the public with easy access to information on publicly and ...

Dubbed ChatGPT Gov, the new tool is a tailored version of ChatGPT classic that allows government agencies to access OpenAI's frontier large language models (LLMs) while still utilizing internal ...

The most recent trading session ended with Novavax (NVAX) standing at $9.34, reflecting a +1.3% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily loss of 1.46%.

Get the latest federal technology news delivered to your inbox. OpenAI unveiled a new chatbot service specifically tailored to federal agency workloads, announcing ChatGPT Gov on Tuesday as the ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs says the company is at a pivot point. In February 2023, Novavax warned ...

Those who want a Novavax jab can book an appointment at a participating Healthier SG clinic from Jan 24, through https://vaccine.gov.sg/covid Those receiving the Novavax vaccine as an additional ...

CHICAGO, Jan 24 (Reuters) - The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and devices in diverse populations as part of a ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...